STC-15

4 Cited Publications
Revisión del cliente

Based on 4 publication(s) in Google Scholar

STC-15 is an orally active RNA methyltransferase METTL3 inhibitor with the activity of activating anti-tumor immunity and reshaping the tumor microenvironment. STC-15 inhibits tumor growth by activating anti-cancer immune responses associated with increased interferon signaling and synergizes with T-cell checkpoint blockade. STC-15 can be used in the study of proliferative diseases such as cancer and autoimmune diseases.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.90%
  • No. CAS: 2648257-56-9
  • Fòrmula: C24H25N5O2
  • Peso molecular:415.49
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00